Keisuke Shioji

Learn More
BACKGROUND Adriamycin (ADR) is an anticancer drug known to cause severe cardiac toxicity by generating free radicals. We investigated the role of a redox-regulating molecule, thioredoxin-1 (TRX1), in ADR-induced cardiotoxicity. METHODS AND RESULTS The in vitro study showed that TRX1 was dose-dependently increased concomitant with the formation of hydroxyl(More)
  • Aoi Ahsan, Yasuyuki Son, Chiharu Ishii, Junji Kishimoto, Wenrui Yodoi, Hajime Liu +15 others
  • 2004
Background—Cardiac myosin–induced myocarditis is an experimental autoimmune myocarditis (EAM) model used to investigate autoimmunological mechanisms in inflammatory heart diseases and resembles fulminant myocarditis in humans. We investigated the therapeutic role of thioredoxin-1 (TRX-1), a redox-regulatory protein with antioxidant and antiinflammatory(More)
  • 1